Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Niloufar Najjar"'
Autor:
Babak Arjmand, Saeed Ebrahimi Fana, Erfan Ghasemi, Ameneh Kazemi, Robabeh Ghodssi-Ghassemabadi, Hojat Dehghanbanadaki, Niloufar Najjar, Ardeshir Kakaii, Katayoon Forouzanfar, Ensieh Nasli-Esfahani, Farshad Farzadfar, Bagher Larijani, Farideh Razi
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Insulin resistance (IR) evolved from excessive energy intake and poor energy expenditure, affecting the patient's quality of life. Amino acid and acylcarnitine metabolomic profiles have identified consistent patterns associated wi
Externí odkaz:
https://doaj.org/article/dce7b14dbc894a018a167b9726080dce
Autor:
Hojat Dehghanbanadaki, Salimeh Dodangeh, Peyvand Parhizkar Roudsari, Shaghayegh Hosseinkhani, Pouria Khashayar, Mohammad Noorchenarboo, Negar Rezaei, Arezou Dilmaghani-Marand, Moein Yoosefi, Babak Arjmand, Kazem Khalagi, Niloufar Najjar, Ardeshir Kakaei, Fatemeh Bandarian, Hamid Aghaei Meybodi, Bagher Larijani, Farideh Razi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundThe intermediate metabolites associated with the development of atherosclerotic cardiovascular disease (ASCVD) remain largely unknown. Thus, we conducted a large panel of metabolomics profiling to identify the new candidate metabolites that
Externí odkaz:
https://doaj.org/article/b271b07c63224611a0bba4f28f5788df
Autor:
Shaghayegh Hosseinkhani, Pooneh Salari, Fatemeh Bandarian, Mojgan Asadi, Shapour Shirani, Niloufar Najjar, Hojat Dehghanbanadaki, Parvin Pasalar, Farideh Razi
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Diabetes mellitus (DM) and its cardiovascular disease (CVD) complication are among the most frequent causes of death worldwide. However, the metabolites linking up diabetes and CVD are less understood. In this study, we aimed to e
Externí odkaz:
https://doaj.org/article/c66ac553a93f44e29d55e3cb6f69427f
Autor:
Shaghayegh Hosseinkhani, Babak Arjmand, Arezou Dilmaghani-Marand, Sahar Mohammadi Fateh, Hojat Dehghanbanadaki, Niloufar Najjar, Sepideh Alavi-Moghadam, Robabeh Ghodssi-Ghassemabadi, Ensieh Nasli-Esfahani, Farshad Farzadfar, Bagher Larijani, Farideh Razi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Diabetes is a common chronic disease affecting millions of people worldwide. It underlies various complications and imposes many costs on individuals and society. Discovering early diagnostic biomarkers takes excellent insight into preventiv
Externí odkaz:
https://doaj.org/article/38ba16dcc3e54cce92dfc37adf459283
Autor:
Hananeh Taghizadeh, Solaleh Emamgholipour, Shaghayegh Hosseinkhani, Babak Arjmand, Negar Rezaei, Arezou Dilmaghani-Marand, Erfan Ghasemi, Nekoo Panahi, Hojat Dehghanbanadaki, Robabeh Ghodssi-Ghassemabadi, Niloufar Najjar, Mojgan Asadi, Mohsen khoshniat, Bagher Larijani, Farideh Razi
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundEvidence, albeit with conflicting results, has suggested that cardiometabolic risk factors, including obesity, type 2 diabetes (T2D), dyslipidemia, and hypertension, are highly associated with changes in metabolic signature, especially plas
Externí odkaz:
https://doaj.org/article/bb2cb731ea7a40a291fbfa485f292b9d
Autor:
Babak Arjmand, Hojat Dehghanbanadaki, Moein Yoosefi, Negar Rezaei, Sahar Mohammadi Fateh, Robabeh Ghodssi-Ghassemabadi, Niloufar Najjar, Shaghayegh Hosseinkhani, Akram Tayanloo-Beik, Hossein Adibi, Farshad Farzadfar, Bagher Larijani, Farideh Razi
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0279835 (2023)
BackgroundIdentification of metabolomics profile in subjects with different blood pressure, including normal blood pressure, elevated blood pressure, stage 1 hypertension, and stage 2 hypertension, would be a promising strategy to understand the path
Externí odkaz:
https://doaj.org/article/2d98a56912b94c848dee52693e248a4d
Autor:
Shaghayegh Hosseinkhani, Solaleh Emamgholipour, Pooneh Salari, Kazem Khalagi, Shapour Shirani, Niloufar Najjar, Bagher Larijani, Parvin Pasalar, Farideh Razi
Publikováno v:
Menopause. 29:1062-1070
Postmenopausal women are at increased risk of developing coronary artery disease (CAD). Metabolomic approaches aim at discovering more helpful biomarkers of CAD to reduce the disease burden in the future. Here, we intend to find potential blood bioma
Autor:
Ali Etemadi, Houra Mobaleghaleslam, Maryam Mirabolghasemi, Mehdi Ahmadi, Hojat Dehghanbanadaki, Shaghayegh Hosseinkhani, Fatemeh Bandarian, Niloufar Najjar, Arezou Dilmaghani-Marand, Nekoo Panahi, Babak Negahdari, Mohammadali Mazloomi, Mohammad Hossein Karimi-jafari, Farideh Razi, Bagher Larijani
Background: The Discovery of underlying intermediates associated with the development of dyslipidemia results in a better understanding of pathophysiology of dyslipidemia and their modification will be a promising preventive and therapeutic strate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aefe4e41393e433289e4d6677326ce7a
https://doi.org/10.21203/rs.3.rs-2400804/v1
https://doi.org/10.21203/rs.3.rs-2400804/v1
Autor:
Shaghayegh Hosseinkhani, Babak Arjmand, Arezou Dilmaghani-Marand, Sahar Mohammadi Fateh, Hojat Dehghanbanadaki, Niloufar Najjar, Sepideh Alavi-Moghadam, Robabeh Ghodssi-Ghassemabadi, Ensieh Nasli-Esfahani, Farshad Farzadfar, Bagher Larijani, Farideh Razi
Publikováno v:
Scientific reports. 12(1)
Diabetes is a common chronic disease affecting millions of people worldwide. It underlies various complications and imposes many costs on individuals and society. Discovering early diagnostic biomarkers takes excellent insight into preventive plans a
Autor:
Fatemeh Bandarian, Farideh Razi, Nastaran Hadizadeh, Parvin Pasalar, Babak Arjmand, Hossein Aazami, Shaghayegh Hosseinkhani, Niloufar Najjar
Publikováno v:
Journal of Diabetes & Metabolic Disorders.
The aim of this study was to evaluate the status of scientific research output of omics in regards to human diseases with more attention shifted toward endocrine and metabolism disorders in Iran, in order to find scientific gaps and also to design fu